Trials / Unknown
UnknownNCT04579146
Coronary Artery Disease (CAD) in Patients HIV-infected
ROLE OF IMMUNE ACTIVATION PROFILES IN CORONARY ATHEROTHROMBOSIS IN PATIENTS HIV-1-INFECTED ON EFFECTIVE ANTIRETROVIRAL THERAPY
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Hôpital Européen Marseille · Academic / Other
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
HIV-infected patients with intermediate-high risk have a high prevalence of CAD and a substantial proportion of obstructive CAD. Degree of stenosis is associated with immunoactivation (lymphocyte and monocyte) and microbial translocation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | coronary computed tomographic angiographic (CCTA) | x-ray examination with contrast by a 64-slice CT coronary angiography. |
Timeline
- Start date
- 2020-09-07
- Primary completion
- 2022-10-01
- Completion
- 2023-10-01
- First posted
- 2020-10-08
- Last updated
- 2022-01-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04579146. Inclusion in this directory is not an endorsement.